Skip to main content
. 2025 Jan 20;15(1):151. doi: 10.3390/biom15010151

Table 6.

Disease management potential of quercetin via the modulation of various activities.

Activity Study Types Animal/Cell Lines Dose Outcomes of the Study Refs.
Cardioprotective In vivo Rats 10 mg/kg
  • High blood pressure and heart rate was decreased quercetin decreased.

[75]
In vivo Rats 20 mg/kg
  • Quercetin demonstrated a detrimental effect on Na, K-ATPase activity by causing a decrease in ATP and Na (+) concentrations.

[76]
In vivo Rats 10 mg/kg
  • Quercetin improved endothelial function and reduced blood pressure.

  • This compound endorsed autophagy.

[77]
Renoprotective In vivo Mice 10 g/kg
  • Quercetin treatment positively reduced polyuria and glycemia.

  • Moreover, it abolished hypertriglyceridemia and impacted renal function.

  • Additionally, improved structural changes in the kidney.

[80]
In vivo Mice 5, 10 mg/kg
  • Creatinine level decreased and histological score improved by quercetin.

[81]
Rats 50 mg/kg
  • GSH levels were improved with quercetin treatment.

  • Histopathological observations revealed decreased levels of NF-κB and eNOS expression after quercetin treatment.

[82]
In vivo Rats 2 mg/kg
  • Pretreatment with quercetin reduced elevated TBARS, reduced renal dysfunction.

  • Renal antioxidant enzymes were restored by quercetin treatment.

[83]
Rats 100 mg/kg
  • Quercetin could overcome cisplatin-induced oxidative stress.

  • It also induced antioxidant gene expression and antioxidant enzyme activity.

[85]
Anti-obesity In vivo Rats 185 mg/kg
  • Quercetin-rich formulation supplemented groups showed a smaller size of adipocytes and much less lipid accumulation.

  • Decreased serum thiobarbituric acid reactive substances.

[88]
Mice 0.1% (weight/weight) quercetin
  • Quercetin attenuated mast cell, macrophage infiltration.

  • Proinflammatory cytokines was lowered by quercetin treatment.

[89]
In vitro 3T3-L1 preadipocytes 0, 10, 50, or 100 μM
  • Expression of adipogenesis-related enzymes was decreased by this compound treatment and attenuated adipogenesis.

  • Induction of apoptosis was noticed in the adipocytes with by the treatment of quercetin.

[90]
In vitro and in vivo 3T3-L1 & Rats 75 and 100 μg/mL and 0.72% OPE
  • Lipid accumulations and TG contents suppressed.

  • mRNA levels of activating protein downregulated.

  • HF + OPE groups reduced weights in the mesenteric fat pad compared with the HF group

[91]
Anti-arthritis In vivo Rats 100 mg/kg
  • Quercetin caused anti-inflammatory effects, lowering jaw volume, downregulating ADA gene expression, reducing levels of RA cytokines.

[94]
In vitro Fibroblast-like synoviocytes 50 nmol/L
  • Expression of XIST and inflammatory cytokines production prevented by quercetin inhibits

[96]
In vitro Fibroblast-like synoviocytes 0, 10, 20, or 30 M
  • Quercetin treatment caused depressed migration and invasion.

  • GATA6 expression was suppressed and the level of miR-146a increased by quercetin.

[98]
Anti-dermatitis In vivo Mice 50 or 100 mg/kg
  • Galangin and quercetin diminish mast cell infiltration and inflammation in the skin, thus attenuating dermatitis.

[39]
In vivo Mice 30, 60, and 120 mg/kg
  • Anti-psoriasis effects were noted by quercetin via improvement in anti-inflammatory status and as an antioxidant.

[99]
In vitro, in vivo HaCaT cells, THP-1, and RAW 264.7, mice 0.01–1 μM and 1 μM and 10 μM
  • Quercetin suppressed the production of pro-inflammatory as well as output of TLR-2.

  • Quercetin reduced skin inflammation

[102]
Effects in respiratory system In vivo Mice 10 mg/kg
  • Quercetin showed less oxidative damage, improvement in the histological pattern, and reduction in cellular influx.

  • Caused improvement in pulmonary emphysema.

[106]
In vitro and in vivo Rats,
NCI-H292 cells
25 and 50 mg/kg
5, 10, or 20 μM
  • Quercetin prevented histopathological changes and attenuated CS-induced inflammatory cell influx.

  • Quercetin attenuated oxidative stress.

[108]
In vitro Human alveolar epithelial cell A549 10, 20, and 40 μM
  • Quercetin attenuated the release of inflammatory markers and nitrite.

  • Quercetin relieves ROS generation and inhibits cell apoptosis.

[8]
Role in oral health In vitro Human oral keratinocytes 20 μM
  • TGF-β3 mRNA and protein levels diminished by quercetin.

  • Expressions of proinflammatory cytokines were downregulated.

[116]
In vitro hOMK107 cells 20, 40, and 80 μM
  • Quercetin caused apoptosis.

  • This flavonoid decreased the inflammatory marker’s production.

[117]
Wound healing effects In vivo Rats Quercetin gel was 5% with a dose of 20 µg
  • The enhancement in wound healing after quercetin administration noted via decreased inflammatory cells and increased fibroblast cells.

[126]
In vivo Rats 10, 20, and 40 mg/mL
  • The wound contraction was the fastest in the quercetin-high dose group.

  • Histopathological studies revealed that collagen deposition and fibroblast distribution was higher in this compound group.

[127]
Anti-colitis effects In vivo Mice 50 mg/kg
  • Quercetin as well as indol-3-carbinol improved clinical symptoms of colitis.

  • Loss of epithelial integrity and inflammation was decreased by quercetin treatment.

[129]
In vivo Mice 500 ppm
  • Quercetin alleviated colitis and strengthened intestinal integrity and liver antioxidant capacity.

[130]
In vivo Mice 25, 50, and 100 mg/kg
  • Quercetin repaired intestinal barrier dysfunction.

[131]
Anti-platelet activation In vivo Rats 5 mg/kg
  • Quercetin remarkably improved the ultrastructural deviation of platelets.

[134]
Anti-depressant effects In vivo Mice 50 mg/kg
  • QUE or FLX treatment improved depression-associated behaviors.

[152]
In vivo Rats 60 mg/kg
  • Quercetin improved the anxiety-depressive-like behavior.

[154]
Role in reproductive system In vivo Rats 50 mg/kg
  • An increased antioxidant enzyme and decrease in Bax gene expression was noted in the quercetin + crude oil vapor group.

[164]
In vivo Rats 50 mg/Kg
  • Quercetin restored hypertension-induced impairment of hormones.

  • Quercetin improves sperm motility as well as viability.

[166]
In vivo Mice 5 mg/Kg
  • Quercetin increased birth spacing and caused reduction in the number of litters.

[168]
Role in bone health In vivo Mice 0.25% (LQ) or 2.5% quercetin
  • Quercetin inhibits bone loss.

[171]
In vivo Rats 15 mg/kg
  • This compound treatment improves bone biomechanical strength and bone structure.

[173]
In vivo Rats 5, 30, and 50 mg/kg
  • Bone loss was prevented by oral administration of quercetin.

[174]
Radioprotective effects In vivo Mice 100 mg/kg
  • Radioprotective effects of quercetin were noted.

[179]
In vivo Mice 20 mg/kg
  • Quercetin in mitigating radiation-induced oxidative stress and scavenged the radiation-induced free radicals.

[180]